Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | $0.04 | $0.09 | $0.06 |
| Q2 2026 | 6 | $0.05 | $0.18 | $0.10 |
| Q3 2026 | 3 | $0.15 | $0.16 | $0.16 |
| Q4 2026 | 4 | $0.19 | $0.21 | $0.20 |
| Q1 2027 | 2 | $0.07 | $0.08 | $0.07 |
| Q2 2027 | 2 | $0.13 | $0.15 | $0.14 |
| Q3 2027 | 2 | $0.21 | $0.23 | $0.22 |
| Q4 2027 | 2 | $0.22 | $0.25 | $0.24 |
Hims & Hers Health Inc last posted its earnings results on Monday, February 23rd, 2026. The company reported $0.08304 earnings per share for the quarter, topping analysts' consensus estimates of $0.02 by $0.06304. The company had revenue of 617.82 M for the quarter and had revenue of 2.35 B for the year. Hims & Hers Health Inc has generated $1 earnings per share over the last year ($0.51 diluted earnings per share) and currently has a price-to-earnings ratio of 27.35. Hims & Hers Health Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/23/2026 | Q4 2025 | $0.02 | $0.09 | 0.07 | $619.23 M | $617.82 M |
| 11/03/2025 | Q3 2025 | $0.09 | $0.07 | -0.02 | $580.24 M | $598.98 M |
| 08/04/2025 | Q2 2025 | $0.18 | $0.19 | 0.01 | $551.67 M | $544.83 M |
| 05/05/2025 | Q1 2025 | $0.12 | $0.22 | 0.1 | $538.59 M | $586.01 M |
| 02/24/2025 | Q4 2024 | $0.09 | $0.12 | 0.03 | $470.85 M | $481.14 M |
| 11/04/2024 | Q3 2024 | $0.06 | $0.35 | 0.29 | $382.20 M | $401.56 M |
| 08/05/2024 | Q2 2024 | $0.04 | $0.06 | 0.02 | $304.66 M | $315.65 M |
| 05/06/2024 | Q1 2024 | $0.01 | $0.05 | 0.04 | $270.37 M | $278.17 M |
| 02/26/2024 | Q4 2023 | $0.00 | $0.01 | 0 | N/A | $246.62 M |
| 11/06/2023 | Q3 2023 | -$0.03 | -$0.04 | -0 | $220.08 M | $226.70 M |
| 08/07/2023 | Q2 2023 | -$0.06 | -$0.03 | 0.03 | $204.95 M | $207.91 M |
| 05/08/2023 | Q1 2023 | -$0.06 | -$0.05 | 0.01 | N/A | $190.77 M |
| 02/27/2023 | Q4 2022 | -$0.07 | -$0.05 | 0.02 | N/A | $167.20 M |
| 11/07/2022 | Q3 2022 | -$0.11 | -$0.09 | 0.02 | $130.32 M | $144.84 M |
| 08/08/2022 | Q2 2022 | -$0.10 | -$0.10 | 0 | $103.89 M | $113.56 M |
| 05/09/2022 | Q1 2022 | -$0.09 | -$0.08 | 0.01 | N/A | $101.31 M |
| 02/24/2022 | Q4 2021 | N/A | -$0.15 | N/A | N/A | $84.70 M |
| 11/10/2021 | Q3 2021 | -$0.14 | -$0.08 | 0.06 | $70.53 M | $74.17 M |
| 08/11/2021 | Q2 2021 | -$0.16 | -$0.05 | 0.11 | $56.49 M | $60.69 M |
| 05/17/2021 | Q1 2021 | -$0.15 | -$0.34 | -0.19 | N/A | $52.31 M |
In the previous quarter, Hims & Hers Health Inc (:HIMS) reported $0.08304 earnings per share (EPS) to beat the analysts' consensus estimate of $0.02 by $0.06304.
The conference call for Hims & Hers Health Inc's latest earnings report can be listened to online.
The conference call transcript for Hims & Hers Health Inc's latest earnings report can be read online.
Hims & Hers Health Inc (:HIMS) has a recorded annual revenue of $2.35 B.
Hims & Hers Health Inc (:HIMS) has a recorded net income of $128.37 M.Hims & Hers Health Inc has generated $0.57 earnings per share over the last four quarters.
Hims & Hers Health Inc (:HIMS) has a price-to-earnings ratio of 27.35 and price/earnings-to-growth ratio is -5.47.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED